Ewing Sarcoma in a Patient with a Multisystem Phenotype: Navigating the Intersection of a Potential Novel Syndrome,...

Ewing sarcoma is a rare, aggressive bone and soft tissue tumor. Its occurrence in a patient with a complex, multisystem congenital history suggests an underlying genetic predisposition and presents significant diagnostic and therapeutic challenges. Associations between sarcomas and scleroderma-like changes, though rare, are documented as paraneoplastic phenomena.

A 26-year-old Arab male with a longstanding history of congenital hearing loss, growth failure, hypothyroidism, and localized scleroderma presented with a popliteal mass. Despite initial management for a scleroderma flare, a biopsy confirmed Ewing sarcoma with bone metastases (stage IVb). Given his complex phenotype and potential underlying DNA repair disorder, a multidisciplinary team initiated a modified chemotherapy regimen (alternating VDC/IE). The initial response was favorable, with tumor necrosis and shrinkage and no significant toxicity.

This report underscores the complex interplay between connective tissue disease, genetic susceptibility, and oncogenesis. It emphasizes the importance of a high index of suspicion for paraneoplastic syndromes or underlying genetic disorders in atypical cancer presentations and advocates for a multidisciplinary, personalized treatment approach to balance efficacy with potential toxicity.